Also, the SLC31A1 expression level is higher in patients with IDH WT status (WT = 246, Mut = 440) and 1p/19q non-codeletion (codel = 171, non-codel = 518), which were proven to have a strong correlation with unfavorable prognostic outcomes in glioma patients (p < 0.01) (Fig. 2D and E). This evidence concerns the gene SLC31A1 and central nervous system cancer.